Cart
sales@molnova.com
Didesmethyl cariprazine
CAS No. 839712-25-3
Didesmethyl cariprazine( —— )
Catalog No. M33340 CAS No. 839712-25-3
Didesmethyl cariprazine, a metabolite of Cariprazine, is the major cyclic active part. Didesmethyl cariprazine has a long half-life of 1-3 weeks.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 302 | In Stock |
|
| 10MG | 449 | In Stock |
|
| 25MG | 706 | In Stock |
|
| 50MG | 930 | In Stock |
|
| 100MG | 1256 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDidesmethyl cariprazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDidesmethyl cariprazine, a metabolite of Cariprazine, is the major cyclic active part. Didesmethyl cariprazine has a long half-life of 1-3 weeks.
-
DescriptionDidesmethyl cariprazine is a metabolite of Cariprazine and acts as the predominant circulating active moiety. Didesmethyl cariprazine has a long half-life of 1-3 weeks. Cariprazine is a antipsychotic agent candidate that exhibits high affinity for the D3 and D2 receptors, and moderate affinity for the 5-HT1A receptor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
Target5-HT Receptor
-
Recptor5-HT Receptor | Dopamine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number839712-25-3
-
Formula Weight399.36
-
Molecular FormulaC19H28Cl2N4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 11.36 mg/mL (28.45 mM; Ultrasonic (<80°C)
-
SMILESNC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2cccc(Cl)c2Cl)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Citrome L, et al. Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy. Neuropsychiatr Dis Treat. 2018 Oct 5;14:2563-2577.?
molnova catalog
related products
-
AVN-101
A higly potent, orally bioavailable, BBB permeable 5-HT7 receptor antagonist with Ki of 153 pM, with slightly lesser potency toward 5-HT6, 5-HT2A and 5HT-2C (Ki?=?1.2-2.0 ?nM).
-
PF-04995274
PF-04995274 (TBPT) is a novel potent, sellective, partial agonist of 5-HT4 receptor under investigation for neurological disorders.
-
5HT6-ligand-1
5HT6-ligand-1 is an orally active ligand of 5-HT6 receptor (Ki = 1.43 nM).
